Takeda Oncology Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 966

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 6

  • Investments
  • 5

Takeda Oncology General Information

Description

Developer of medicines for the treatment of cancer. The company offers medicines and therapy for cancer treatment.

Contact Information

Formerly Known As
Millennium Pharmaceuticals
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Takeda Pharmaceutical Company
Primary Office
  • 40 Landsdowne Street
  • Cambridge, MA 02139
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Takeda Oncology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Takeda Oncology‘s full profile, request access.

Request a free trial

Takeda Oncology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medicines for the treatment of cancer. The company offers medicines and therapy for cancer treatment.
Drug Discovery
Cambridge, MA
966 As of 2008
0000
0.00 0000-00-00
000000&0 0000

000 00

magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labori
000000000000000
Seattle, WA
000 As of 0000
00000
0.00 0000-00-00
000000&0 00000

000000

consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolo
0000 000000000
Torrance, CA
00 As of 0000
000.00
000000000 - 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Takeda Oncology Competitors (46)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CTI BioPharma Formerly VC-backed Seattle, WA 000 00000 000000&0 00000
000000 0000 000000 Formerly VC-backed Torrance, CA 00 000.00 000000000 - 000.00
000 000000 00000 Private Debt Financed Bresso, Italy 0000 000.00 000000000 000.00
000 00000 Corporation Indianapolis, IN 00000 000.00 000000000 000.00
0000000000 0000000 Formerly VC-backed Newton, MA 000 00000 000000000 00000
You’re viewing 5 of 46 competitors. Get the full list »

Takeda Oncology Patents

  • 5,182

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 81

    Granted

  • 17

    Pending

  • 000

    Expiring in next 12 mo

Takeda Oncology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Takeda Oncology Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Takeda Oncology‘s full profile, request access.

Request a free trial

Takeda Oncology Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ingenuity Systems 29-Jul-2003 00000 0000 00.000 Other Healthcare Technology Systems
COR Therapeutics 06-Dec-2001 0000000000 00.00 Drug Discovery 000000000
LeukoSite 01-Jan-2000 0000000000 00000 Biotechnology
Myco Pharmaceuticals 01-Jan-1997 0000000000 Drug Delivery
SGX Pharmaceuticals PE Growth/Expansion Pharmaceuticals
To view Takeda Oncology’s complete investments and acquisitions history, request access »

Takeda Oncology Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
Ingenuity Systems 29-Jul-2003 00000 00000 00 00.000 Completed
  • 7 buyers
SGX Pharmaceuticals PE Growth/Expansion Completed
  • 3 buyers
To view Takeda Oncology’s complete exits history, request access »